Since long surgical excision of the tumors, followed by anti-cancer therapy, and irradiation were the basic tenets of management of all malignancies. Recently, Dendritic Cells (DCs) therapy has appeared on the horizon as a sparkling star in the management of cancer by way of Immunotherapy. DCs are essential cells that protect the human body through effective T cell actions against tumor antigens. All electronic databases for English language literature were searched which included Pub Med, Scopus, Web of Science, EBSCO Cumulative Index to Allied Health Literature, and Cochrane Central with key words of cancer, immunotherapy, dendritic cell vaccines. Our review scrutinizes salient features of how DCs form the basis of the adaptive natural immunity and play a central role in neutralizing cancer cells through T-cell responses against cancer antigens. Reports indicate that DCs actively limit tumor growth and are also involved in interfering with metastasis growth. This review aims to elucidate the benefits of DC therapy in various tumors critically.
Steinman, R.M. and Cohn, Z.A. (1973) Identification of a Novel Cell Type in Peripheral Lymphoid Organs of Mice. The Journal of Experimental Medicine , 137, 1142-1162. https://doi.org/10.1084/jem.137.5.1142
Steinman, R.M. and Nussenzweig, M.C. (2002) Avoiding Horror Autotoxicus: The Importance of Dendritic Cells in Peripheral T Cell Tolerance. Proceedings of the National Academy of Sciences , 99, 351-358. https://doi.org/10.1073/pnas.231606698
Horn, L., Spigel, D.R., Vokes, E.E., Holgado, E., Ready, N., Steins, M., et al . (2017) Nivolumab versus Docetaxel in Previously Treated Patients with Advanced Non–small-Cell Lung Cancer: Two-Year Outcomes from Two Randomized, Open-Label, Phase III Trials (CheckMate 017 and CheckMate 057). Journal of Clinical Oncology , 35, 3924-3933. https://doi.org/10.1200/jco.2017.74.3062
Steinman, R.M. and Witmer, M.D. (1978) Lymphoid Dendritic Cells Are Potent Stimulators of the Primary Mixed Leukocyte Reaction in Mice. Proceedings of the National Academy of Sciences , 75, 5132-5136. https://doi.org/10.1073/pnas.75.10.5132
Collin, M., McGovern, N. and Haniffa, M. (2013) Human Dendritic Cell Subsets. Immunology , 140, 22-30. https://doi.org/10.1111/imm.12117
See, P., Dutertre, C., Chen, J., Günther, P., McGovern, N., Irac, S.E., et al . (2017) Mapping the Human DC Lineage through the Integration of High-Dimensional Techniques. Science , 356, eaag3009. https://doi.org/10.1126/science.aag3009
Brown, C.C., Gudjonson, H., Pritykin, Y., Deep, D., Lavallée, V., Mendoza, A., et al . (2019) Transcriptional Basis of Mouse and Human Dendritic Cell Heterogeneity. Cell , 179, 846-863.e24. https://doi.org/10.1016/j.cell.2019.09.035
Gerhard, G.M., Bill, R., Messemaker, M., Klein, A.M. and Pittet, M.J. (2020) Tumor-infiltrating Dendritic Cell States Are Conserved across Solid Human Cancers. Journal of Experimental Medicine , 218, e20200264. https://doi.org/10.1084/jem.20200264
Chudnovskiy, A., Pasqual, G. and Victora, G.D. (2019) Studying Interactions between Dendritic Cells and T Cells in Vivo . Current Opinion in Immunology , 58, 24-30. https://doi.org/10.1016/j.coi.2019.02.002
Liu, K. (2016) Dendritic Cells. In: Encyclopedia of Cell Biology , Elsevier, 741-749. https://doi.org/10.1016/b978-0-12-394447-4.30111-0
Merad, M., Sathe, P., Helft, J., Miller, J. and Mortha, A. (2013) The Dendritic Cell Lineage: Ontogeny and Function of Dendritic Cells and Their Subsets in the Steady State and the Inflamed Setting. Annual Review of Immunology , 31, 563-604. https://doi.org/10.1146/annurev-immunol-020711-074950
Chen, D.S. and Mellman, I. (2013) Oncology Meets Immunology: The Cancer-Immunity Cycle. Immunity , 39, 1-10. https://doi.org/10.1016/j.immuni.2013.07.012
Wu, R. and Murphy, K.M. (2022) DCs at the Center of Help: Origins and Evolution of the Three-Cell-Type Hypothesis. Journal of Experimental Medicine , 219, e20211519. https://doi.org/10.1084/jem.20211519
Mehrani, Y., Morovati, S., Keivan, F., Sarmadi, S., Shojaei, S., Forouzanpour, D., et al . (2025) Dendritic Cell-Based Cancer Vaccines: The Impact of Modulating Innate Lymphoid Cells on Anti-Tumor Efficacy. Cells , 14, Article No. 812. https://doi.org/10.3390/cells14110812
Duarte, A.d.S.S., Zangirolami, A.B., Santos, I., Niemann, F.S., Honma, H.N., Amaro, E.C., et al . (2024) Production of Dendritic Cell Vaccines Using Different Methods with Equivalent Results: Implications for Emerging Centers. Hematology , Transfusion and Cell Therapy , 46, 30-35. https://doi.org/10.1016/j.htct.2022.11.006
Palomares, F., Pina, A., Dakhaoui, H., Leiva-Castro, C., Munera-Rodriguez, A.M., Cejudo-Guillen, M., et al . (2024) Dendritic Cells as a Therapeutic Strategy in Acute Myeloid Leukemia: Vaccines. Vaccines , 12, Article No. 165. https://doi.org/10.3390/vaccines12020165
Kowalewicz-Kulbat, M., Ograczyk, E., Krawczyk, K., Rudnicka, W. and Fol, M. (2016) Type of Monocyte Immunomagnetic Separation Affects the Morphology of Monocyte-Derived Dendritic Cells, as Investigated by Scanning Electron Microscopy. Jour nal of Immunological Methods , 439, 79-82. https://doi.org/10.1016/j.jim.2016.10.004
Sosa Cuevas, E., Saas, P. and Aspord, C. (2023) Dendritic Cell Subsets in Melanoma: Pathophysiology, Clinical Prognosis and Therapeutic Exploitation. Cancers , 15, Article No. 2206. https://doi.org/10.3390/cancers15082206
Bergengren, O., Pekala, K.R., Matsoukas, K., Fainberg, J., Mungovan, S.F., Bratt, O., et al . (2023) 2022 Update on Prostate Cancer Epidemiology and Risk Factors—A Systematic Review. European Urology , 84, 191-206. https://doi.org/10.1016/j.eururo.2023.04.021
World Health Organization (2022) Global Health Estimates.
Sankarapillai, J., Krishnan, S., Ramamoorthy, T., Sudarshan, K.L. and Mathur, P. (2024) Descriptive Epidemiology of Prostate Cancer in India, 2012-2019: Insights from the National Cancer Registry Programme. Indian Journal of Urology , 40, 167-173. https://doi.org/10.4103/iju.iju_27_24
Steinbach, C., Merchant, A., Zaharie, A., Horak, P., Marhold, M. and Krainer, M. (2022) Current Developments in Cellular Therapy for Castration Resistant Prostate Cancer: A Systematic Review of Clinical Studies. Cancers , 14, Article No. 5719. https://doi.org/10.3390/cancers14225719
Huang, F., Li, K., Shevach, J.W. and Wang, Q. (2025) Emerging Therapies to Overcome Antiandrogen Resistance and Beyond in Lethal Prostate Cancer. Journal of the National Cancer Center . https://doi.org/10.1016/j.jncc.2025.04.004
Westdorp, H., Creemers, J.H.A., van Oort, I.M., Schreibelt, G., Gorris, M.A.J., Mehra, N., et al . (2019) Blood-Derived Dendritic Cell Vaccinations Induce Immune Responses That Correlate with Clinical Outcome in Patients with Chemo-Naive Castration-Resistant Prostate Cancer. Journal for ImmunoTherapy of Cancer , 7, Article No. 302. https://doi.org/10.1186/s40425-019-0787-6
Tryggestad, A.M.A., Axcrona, K., Axcrona, U., Bigalke, I., Brennhovd, B., Inderberg, E.M., et al . (2021) Long-Term First-in-Man Phase I/II Study of an Adjuvant Dendritic Cell Vaccine in Patients with High-risk Prostate Cancer after Radical Prostatectomy. The Prostate , 82, 245-253. https://doi.org/10.1002/pros.24267
Arzanova, E. and Mayrovitz, H.N. (2022) The Epidemiology of Breast Cancer. In: Mayrovitz, H.N., Ed., Breast Cancer , Exon Publications, 1-20. https://doi.org/10.36255/exon-publications-breast-cancer-epidemiology
Ishiba, T., Aruga, T., Miyamoto, H., Ishihara, S., Nara, M., Adachi, M., et al . (2021) Short-and Long-Term Outcomes of Immediate Breast Reconstruction Surgery after Neoadjuvant Chemotherapy. Surgery Today , 52, 129-136. https://doi.org/10.1007/s00595-021-02316-3
Breast Cancer. https://www.who.int/news-room/fact-sheets/detail/breast-cancer
International Agency for Research on Cancer. India Source: Globocan 2020. https://gco.iarc.fr/today/data/factsheets/populations/356-india-fact-sheets.pdf
Bernal-Estévez, D.A., Ortíz Barbosa, M.A., Ortíz-Montero, P., Cifuentes, C., Sánchez, R. and Parra-López, C.A. (2021) Autologous Dendritic Cells in Combination with Chemotherapy Restore Responsiveness of T Cells in Breast Cancer Patients: A Single-Arm Phase I/II Trial. Frontiers in Immunology , 12, Article ID: 669965. https://doi.org/10.3389/fimmu.2021.669965
Santisteban, M., Solans, B.P., Hato, L., Urrizola, A., Mejías, L.D., Salgado, E., et al . (2021) Final Results Regarding the Addition of Dendritic Cell Vaccines to Neoadjuvant Chemotherapy in Early HER2-Negative Breast Cancer Patients: Clinical and Translational Analysis. Therapeutic Advances in Medical Oncology , 13. https://doi.org/10.1177/17588359211064653
Soliman, H., Aldrich, A., Abdo, N., Han, H., Soyano, A., Costa, R., et al . (2025) A Pilot Study Incorporating HER2-Directed Dendritic Cells into Neoadjuvant Therapy of Early Stage HER2+ER-Breast Cancer. NPJ Breast Cancer , 11, Article No. 29. https://doi.org/10.1038/s41523-025-00742-x
Kodumudi, K.N., Ramamoorthi, G., Snyder, C., Basu, A., Jia, Y., Awshah, S., et al . (2019) Sequential Anti-PD1 Therapy Following Dendritic Cell Vaccination Improves Survival in a HER2 Mammary Carcinoma Model and Identifies a Critical Role for CD4 T Cells in Mediating the Response. Frontiers in Immunology , 10, Article No. 1939. https://doi.org/10.3389/fimmu.2019.01939
Maeng, H.M., Moore, B.N., Bagheri, H., Steinberg, S.M., Inglefield, J., Dunham, K., et al . (2021) Phase I Clinical Trial of an Autologous Dendritic Cell Vaccine against HER2 Shows Safety and Preliminary Clinical Efficacy. Frontiers in Oncology , 11, Article ID: 789078. https://doi.org/10.3389/fonc.2021.789078
Lowenfeld, L., Mick, R., Datta, J., Xu, S., Fitzpatrick, E., Fisher, C.S., et al . (2017) Dendritic Cell Vaccination Enhances Immune Responses and Induces Regression of Her2pos DCIS Independent of Route: Results of Randomized Selection Design Trial. Clinical Cancer Research , 23, 2961-2971. https://doi.org/10.1158/1078-0432.ccr-16-1924
Lowenfeld, L., Zaheer, S., Oechsle, C., Fracol, M., Datta, J., Xu, S., et al . (2016) Addition of Anti-Estrogen Therapy to Anti-HER2 Dendritic Cell Vaccination Improves Regional Nodal Immune Response and Pathologic Complete Response Rate in Patients with ER pos /HER2 pos Early Breast Cancer. OncoImmunology , 6, e1207032. https://doi.org/10.1080/2162402x.2016.1207032
Delgado-Martín, B. and Medina, M.Á. (2020) Advances in the Knowledge of the Molecular Biology of Glioblastoma and Its Impact in Patient Diagnosis, Stratification, and Treatment. Advanced Science , 7, Article ID: 1902971. https://doi.org/10.1002/advs.201902971
Tan, A.C., Ashley, D.M., López, G.Y., Malinzak, M., Friedman, H.S. and Khasraw, M. (2020) Management of Glioblastoma: State of the Art and Future Directions. CA : A Cancer Journal for Clinicians , 70, 299-312. https://doi.org/10.3322/caac.21613
Grochans, S., Cybulska, A.M., Simińska, D., Korbecki, J., Kojder, K., Chlubek, D., et al . (2022) Epidemiology of Glioblastoma Multiforme-Literature Review. Cancers , 14, Article No. 2412. https://doi.org/10.3390/cancers14102412
Grech, N., Dalli, T., Mizzi, S., Meilak, L., Calleja, N. and Zrinzo, A. (2020) Rising Incidence of Glioblastoma Multiforme in a Well-Defined Population. Cureu s , 12, e8195. https://doi.org/10.7759/cureus.8195
Faust Akl, C., Andersen, B.M., Li, Z., Giovannoni, F., Diebold, M., Sanmarco, L.M., et al . (2025) Glioblastoma-Instructed Astrocytes Suppress Tumour-Specific T Cell Immunity. Nature , 643, 219-229. https://doi.org/10.1038/s41586-025-08997-x
Ostrom, Q.T., Price, M., Neff, C., Cioffi, G., Waite, K.A., Kruchko, C., et al . (2023) CBTRUS Statistical Report: Primary Brain and Other Central Nervous System Tumors Diagnosed in the United States in 2016-2020. Neuro - Oncology , 25, iv1-iv99. https://doi.org/10.1093/neuonc/noad149
van Opijnen, M.P., Nabuurs, R.J.A., de Vos, F.Y.F., Ramsoedh, M.T.R., Verhoeff, J.J.C., Geurts, M., et al . (2024) Recurrent Glioblastoma in National Guidelines on the Diagnosis and Treatment of Gliomas: A Matter of European Practice Variation. Brain and Spine , 4, Article ID: 103923. https://doi.org/10.1016/j.bas.2024.103923
Zhou, J., Li, L., Jia, M., Liao, Q., Peng, G., Luo, G., et al . (2022) Dendritic Cell Vaccines Improve the Glioma Microenvironment: Influence, Challenges, and Future Directions. Cancer Medicine , 12, 7207-7221. https://doi.org/10.1002/cam4.5511
Eagles, M., Nassiri, F., Badhiwala, J., Suppiah, S., Almenawer, S., Zadeh, G., et al . (2018) Dendritic Cell Vaccines for High-Grade Gliomas. Therapeutics and Clinical Risk Management , 14, 1299-1313. https://doi.org/10.2147/tcrm.s135865
Lv, L., Huang, J., Xi, H. and Zhou, X. (2020) Efficacy and Safety of Dendritic Cell Vaccines for Patients with Glioblastoma: A Meta-Analysis of Randomized Controlled Trials. International Immunopharmacology , 83, Article ID: 106336. https://doi.org/10.1016/j.intimp.2020.106336
Cozzi, S., Najafi, M., Gomar, M., Ciammella, P., Iotti, C., Iaccarino, C., et al . (2022) Delayed Effect of Dendritic Cells Vaccination on Survival in Glioblastoma: A Systematic Review and Meta-Analysis. Current Oncology , 29, 881-891. https://doi.org/10.3390/curroncol29020075
Wong, C., Chang, Y., Chen, P., Huang, Y., Chang, Y., Chiang, C., et al . (2024) Dendritic Cell Vaccine for Glioblastoma: An Updated Meta-Analysis and Trial Sequential Analysis. Journal of Neuro-Oncology , 170, 253-263. https://doi.org/10.1007/s11060-024-04798-w
Ramnath, N., Ganesan, P., Penumadu, P., Arenberg, D. and Bryant, A. (2025) Lung Cancer Screening in India: Preparing for the Future Using Smart Tools & Biomarkers to Identify Highest Risk Individuals. The Indian Journal of Medical Research , 160, 561-569. https://doi.org/10.25259/ijmr_118_24
Nath, A., Sathishkumar, K., Das, P., Sudarshan, K.L. and Mathur, P. (2022) A Clinicoepidemiological Profile of Lung Cancers in India—Results from the National Cancer Registry Programme. Indian Journal of Medical Research , 155, 264-272. https://doi.org/10.4103/ijmr.ijmr_1364_21
Garg, A., Iyer, H., Jindal, V., Vashistha, V., Ali, A., Jain, D., et al . (2022) Prognostic Factors for Treatment Response and Survival Outcomes after First-Line Management of Stage 4 Non-Small Cell Lung Cancer: A Real-World Indian Perspective. Lung India , 39, 102-109. https://doi.org/10.4103/lungindia.lungindia_408_21
Punekar, S.R., Shum, E., Grello, C.M., Lau, S.C. and Velcheti, V. (2022) Immunotherapy in Non-Small Cell Lung Cancer: Past, Present, and Future Directions. Frontiers in Oncology , 12, Article ID: 877594. https://doi.org/10.3389/fonc.2022.877594
Reck, M., Rodríguez-Abreu, D., Robinson, A.G., Hui, R., Csőszi, T., Fülöp, A., et al . (2021) Five-Year Outcomes with Pembrolizumab versus Chemotherapy for Metastatic Non-Small-Cell Lung Cancer with PD-L1 Tumor Proportion Score ≥ 50%. Journal of Clinical Oncology , 39, 2339-2349. https://doi.org/10.1200/jco.21.00174
Shields, M.D., Marin-Acevedo, J.A. and Pellini, B. (2021) Immunotherapy for Advanced Non-Small Cell Lung Cancer: A Decade of Progress. American Society of Clinical Oncology Educational Book , 41, e105-e127. https://doi.org/10.1200/edbk_321483
Hu, R.H. Shi, S.B., Qi, J.L., Tian, J., Tang, X., Liu, G., et al . (2014) Pemetrexed Plus Dendritic Cells as Second-Line Treatment for Patients with Stage IIIB/IV Non-Small Cell Lung Cancer Who Had Treatment with TKI. Medical Oncology , 31, Article No. 63. https://doi.org/10.1007/s12032-014-0063-z
Takahashi, H., Shimodaira, S., Ogasawara, M., Ota, S., Kobayashi, M., Abe, H., et al . (2016) Lung Adenocarcinoma May Be a More Susceptive Subtype to a Dendritic Cell-Based Cancer Vaccine than Other Subtypes of Non-Small Cell Lung Cancers: A Multicenter Retrospective Analysis. Cancer Immunology , Immunotherapy , 65, 1099-1111. https://doi.org/10.1007/s00262-016-1872-z
Zemanova, M., Cernovska, M., Havel, L., Bartek, T., Lukesova, S., Jakesova, J., et al . (2021) Autologous Dendritic Cell-Based Immunotherapy (DCVAC/LuCa) and Carboplatin/Paclitaxel in Advanced Non-Small Cell Lung Cancer: A Randomized, Open-Label, Phase I/II Trial. Cancer Treatment and Research Communications , 28, Article ID: 100427. https://doi.org/10.1016/j.ctarc.2021.100427
Zhong, R., Ling, X., Cao, S., Xu, J., Zhang, B., Zhang, X., et al . (2022) Safety and Efficacy of Dendritic Cell-Based Immunotherapy (DCVAC/LuCa) Combined with Carboplatin/Pemetrexed for Patients with Advanced Non-Squamous Non-Small-Cell Lung Cancer without Oncogenic Drivers. ESMO Open , 7, Article ID: 100334. https://doi.org/10.1016/j.esmoop.2021.100334
Huang, J., Chan, S.C., Ngai, C.H., Lok, V., Zhang, L., Lucero-Prisno, D.E., et al . (2022) Disease Burden, Risk Factors, and Trends of Leukaemia: A Global Analysis. Frontiers in Oncology , 12, Article ID: 904292. https://doi.org/10.3389/fonc.2022.904292
Nalage, D.N., Kudnar, P.S., Langhe, R., Ughade, B., Sontakke, T. and Biradar, A. (2024) Leukemia in India: Insights into Incidence, Prevalence, Mortality, and Disability-Adjusted Life Years. Cureus , 16, e62557. https://doi.org/10.7759/cureus.62557
Döhner, H., Wei, A.H., Appelbaum, F.R., Craddock, C., DiNardo, C.D., Dombret, H., et al . (2022) Diagnosis and Management of AML in Adults: 2022 Recommendations from an International Expert Panel on Behalf of the ELN. Blood , 140, 1345-1377. https://doi.org/10.1182/blood.2022016867
Vago, L. and Gojo, I. (2020) Immune Escape and Immunotherapy of Acute Myeloid Leukemia. Journal of Clinical Investigation , 130, 1552-1564. https://doi.org/10.1172/jci129204
Abadir, E., Gasiorowski, R.E., Silveira, P.A., Larsen, S. and Clark, G.J. (2020) Is Hematopoietic Stem Cell Transplantation Required to Unleash the Full Potential of Immunotherapy in Acute Myeloid Leukemia? Journal of Clinical Medicine , 9, Article No. 554. https://doi.org/10.3390/jcm9020554
Lau, C.M., Nish, S.A., Yogev, N., Waisman, A., Reiner, S.L. and Reizis, B. (2016) Leukemia-Associated Activating Mutation of Flt3 Expands Dendritic Cells and Alters T Cell Responses. Journal of Experimental Medicine , 213, 415-431. https://doi.org/10.1084/jem.20150642
Gaafar, A., Al-Omar, H.M., Manogaran, P.S., Almohareb, F. and Alhussein, K. (2023) Prevalence of the BCR/ABL Fusion Gene and T Cell Stimulation Capacity of Dendritic Cells in Chronic Myelogenous Leukemia. American Journal of Translational Research , 15, 967-981.
Hsieh, Y., Kirschner, K. and Copland, M. (2021) Improving Outcomes in Chronic Myeloid Leukemia through Harnessing the Immunological Landscape. Leukemia , 35, 1229-1242. https://doi.org/10.1038/s41375-021-01238-w
Stein, J., Anand, P., Abdulmajid, J., Hartz, A., Unterfrauner, M., Feng, X., et al . (2025) Monitoring of (Leukemia-Specific) Immune Cells in Stages, Treatment Groups and in the Course of Disease and Therapy Contributes to Qualify Antileukemic Potential and Survival in Patients with Aml. International Journal of Molecular Sciences , 26, Article No. 10336. https://doi.org/10.3390/ijms262110336
Fujii, S., Shimizu, K., Fujimoto, K., Kiyokawa, T., Shimomura, T., Taniguchi, O., et al . (1999) Analysis of a Chronic Myelogenous Leukemia Patient Vaccinated with Leukemic Dendritic Cells Following Autologous Peripheral Blood Stem Cell Transplantation. Japanese Journal of Cancer Research , 90, 1117-1129. https://doi.org/10.1111/j.1349-7006.1999.tb00686.x
van de Loosdrecht, A.A., van Wetering, S., Santegoets, S.J.A.M., Singh, S.K., Eeltink, C.M., den Hartog, Y., et al . (2018) A Novel Allogeneic Off-the-Shelf Dendritic Cell Vaccine for Post-Remission Treatment of Elderly Patients with Acute Myeloid Leukemia. Cancer Immunology , Immunotherapy , 67, 1505-1518. https://doi.org/10.1007/s00262-018-2198-9
Anguille, S., Van de Velde, A.L., Smits, E.L., Van Tendeloo, V.F., Juliusson, G., Cools, N., et al . (2017) Dendritic Cell Vaccination as Postremission Treatment to Prevent or Delay Relapse in Acute Myeloid Leukemia. Blood , 130, 1713-1721. https://doi.org/10.1182/blood-2017-04-780155
Zanotta, S., Galati, D., De Filippi, R. and Pinto, A. (2024) Enhancing Dendritic Cell Cancer Vaccination: The Synergy of Immune Checkpoint Inhibitors in Combined Therapies. International Journal of Molecular Sciences , 25, Article No. 7509. https://doi.org/10.3390/ijms25147509
Gardner, A., de Mingo Pulido, Á. and Ruffell, B. (2020) Dendritic Cells and Their Role in Immunotherapy. Frontiers in Immunology , 11, Article No. 924. https://doi.org/10.3389/fimmu.2020.00924
Miao, L., Zhang, Y. and Huang, L. (2021) mRNA Vaccine for Cancer Immunotherapy. Molecular Cancer , 20, Article No. 41. https://doi.org/10.1186/s12943-021-01335-5
Duan, L., Wang, Q., Zhang, C., Yang, D. and Zhang, X. (2022) Potentialities and Challenges of mRNA Vaccine in Cancer Immunotherapy. Frontiers in Immunology , 13, Article ID: 923647. https://doi.org/10.3389/fimmu.2022.923647
Wculek, S.K., Cueto, F.J., Mujal, A.M., Melero, I., Krummel, M.F. and Sancho, D. (2019) Dendritic Cells in Cancer Immunology and Immunotherapy. Nature Reviews Immunology , 20, 7-24. https://doi.org/10.1038/s41577-019-0210-z
Stavrou, V., Fultang, L., Booth, S., De Simone, D., Bartnik, A., Scarpa, U., et al . (2022) Invariant NKT Cells Metabolically Adapt to the Acute Myeloid Leukaemia Environment. Cancer Immunology , Immunotherapy , 72, 543-560. https://doi.org/10.1007/s00262-022-03268-4
Fløisand, Y., Remberger, M., Bigalke, I., Josefsen, D., Vålerhaugen, H., Inderberg, E.M., et al . (2023) WT1 and PRAME RNA-Loaded Dendritic Cell Vaccine as Maintenance Therapy in De Novo AML after Intensive Induction Chemotherapy. Leukemia , 37, 1842-1849. https://doi.org/10.1038/s41375-023-01980-3
O’Brien, L.J., Guillerey, C. and Radford, K.J. (2019) Can Dendritic Cell Vaccination Prevent Leukemia Relapse? Cancers , 11, Article No. 875. https://doi.org/10.3390/cancers11060875
Gupta, K., Mandal, R. and Chatterjee, P. (2024) Navigating the Landscape of Cervical Cancer in India: Epidemiology, Prevention, Current Status, and Emerging Solutions. Journal of Obstetrics and Gynaecology Research , 50, 55-64. https://doi.org/10.1111/jog.16030
Okita, T., Enzo, A., Kadooka, Y., Tanaka, M. and Asai, A. (2020) The Controversy on HPV Vaccination in Japan: Criticism of the Ethical Validity of the Arguments for the Suspension of the Proactive Recommendation. Health Policy , 124, 199-204. https://doi.org/10.1016/j.healthpol.2019.12.011
Bandyopadhyay, A., Mukherjee, U., Ghosh, S., Ghosh, S. and Sarkar, S.K. (2018) Pattern of Failure with Locally Advanced Cervical Cancer—A Retrospective Audit and Analysis of Contributory Factors. Asian Pacific Journal of Cancer Prevention , 19, 73-79.
Zheng, Q., He, M., Mao, Z., Huang, Y., Li, X., Long, L., et al . (2025) Advancing the Fight against Cervical Cancer: The Promise of Therapeutic HPV Vaccines. Vaccines , 13, Article No. 92. https://doi.org/10.3390/vaccines13010092
Santin, A.D., Bellone, S., Palmieri, M., Zanolini, A., Ravaggi, A., Siegel, E.R., et al . (2008) Human Papillomavirus Type 16 and 18 E7-Pulsed Dendritic Cell Vaccination of Stage IB or IIA Cervical Cancer Patients: A Phase I Escalating-Dose Trial. Journal of Virology , 82, 1968-1979. https://doi.org/10.1128/jvi.02343-07
Lin, H., Wu, C., Fu, H. and Ou, Y. (2025) Recent Advances in Cervical Cancer Treatment: Innovations from Early-Stage to Advanced Disease. Journal of Obstetrics and Gynecology , 64, 608-615. https://doi.org/10.1016/j.tjog.2025.04.006
Tewari, K.S., Sill, M.W., Long, H.J., Penson, R.T., Huang, H., Ramondetta, L.M., et al . (2014) Improved Survival with Bevacizumab in Advanced Cervical Cancer. New England Journal of Medicine , 370, 734-743. https://doi.org/10.1056/nejmoa1309748
Bermudez, A., Bhatla, N. and Leung, E. (2015) Cancer of the Cervix Uteri. International Journal of Gynecology & Obstetrics , 131, S88-S95. https://doi.org/10.1016/j.ijgo.2015.06.004
Amatore, F., Gorvel, L. and Olive, D. (2018) Inducible Co-Stimulator (ICOS) as a Potential Therapeutic Target for Anti-Cancer Therapy. Expert Opinion on Therapeutic Targets , 22, 343-351. https://doi.org/10.1080/14728222.2018.1444753
Compte, M., Harwood, S.L., Muñoz, I.G., Navarro, R., Zonca, M., Perez-Chacon, G., et al . (2018) A Tumor-Targeted Trimeric 4-1BB-Agonistic Antibody Induces Potent Anti-Tumor Immunity without Systemic Toxicity. Nature Communications , 9, Article No. 4809. https://doi.org/10.1038/s41467-018-07195-w
Polesso, F., Weinberg, A.D. and Moran, A.E. (2019) Late-stage Tumor Regression after PD-L1 Blockade Plus a Concurrent OX40 Agonist. Cancer Immunology Research , 7, 269-281. https://doi.org/10.1158/2326-6066.cir-18-0222
Dey, T. and Agrawal, S. (2025) Immunotherapy in Cervical Cancer: An Innovative Approach for Better Treatment Outcomes. Exploration of Targeted Anti- Tumor Therapy , 6, Article ID: 1002296. https://doi.org/10.37349/etat.2025.1002296
Ghosh, T.S., Das, M., Jeffery, I.B. and O’Toole, P.W. (2020) Adjusting for Age Improves Identification of Gut Microbiome Alterations in Multiple Diseases. eLife , 9, e50240. https://doi.org/10.7554/elife.50240
Roshandel, G., Ghasemi-Kebria, F. and Malekzadeh, R. (2024) Colorectal Cancer: Epidemiology, Risk Factors, and Prevention. Cancers , 16, Article No. 1530. https://doi.org/10.3390/cancers16081530
Sato, Y., Tsujinaka, S., Miura, T., Kitamura, Y., Suzuki, H. and Shibata, C. (2023) Inflammatory Bowel Disease and Colorectal Cancer: Epidemiology, Etiology, Surveillance, and Management. Cancers , 15, Article No. 4154. https://doi.org/10.3390/cancers15164154
Lee, C., Kim, M., Kumar, A., Lee, H., Yang, Y. and Kim, Y. (2025) Vascular Endothelial Growth Factor Signaling in Health and Disease: From Molecular Mechanisms to Therapeutic Perspectives. Signal Transduction and Targeted Therapy , 10, Article No. 170. https://doi.org/10.1038/s41392-025-02249-0
Shivshankar, S., Patil, P.S., Deodhar, K. and Budukh, A.M. (2025) Epidemiology of Colorectal Cancer: A Review with Special Emphasis on India. Indian Journal of Gastroenterology , 44, 142-153. https://doi.org/10.1007/s12664-024-01726-8
Bray, F., Ferlay, J., Soerjomataram, I., Siegel, R.L., Torre, L.A. and Jemal, A. (2018) Global Cancer Statistics 2018: GLOBOCAN Estimates of Incidence and Mortality Worldwide for 36 Cancers in 185 Countries. CA : A Cancer Journal for Clinicians , 68, 394-424. https://doi.org/10.3322/caac.21492
Lee, S., Surabhi, V.R., Kassam, Z., Chang, K.J. and Kaur, H. (2023) Imaging of Colon and Rectal Cancer. Current Problems in Cancer , 47, Article ID: 100970. https://doi.org/10.1016/j.currproblcancer.2023.100970
Cervantes, A., Adam, R., Roselló, S., Arnold, D., Normanno, N., Taïeb, J., et al . (2023) Metastatic Colorectal Cancer: ESMO Clinical Practice Guideline for Diagnosis, Treatment and Follow-up. Annals of Oncology , 34, 10-32. https://doi.org/10.1016/j.annonc.2022.10.003
Biller, L.H. and Schrag, D. (2021) Diagnosis and Treatment of Metastatic Colorectal Cancer: A Review. JAMA , 325, 669-685. https://doi.org/10.1001/jama.2021.0106
Heras-Murillo, I., Adán-Barrientos, I., Galán, M., Wculek, S.K. and Sancho, D. (2024) Dendritic Cells as Orchestrators of Anticancer Immunity and Immunotherapy. Nature Reviews Clinical Oncology , 21, 257-277. https://doi.org/10.1038/s41571-024-00859-1
Hsieh, H.H., Chen, C.L., Chan, H.W., Chi, K. and Wu, C. (2023) Enhanced Antitumour Response of Gold Nanostar-Mediated Photothermal Therapy in Combination with Immunotherapy in a Mouse Model of Colon Carcinoma. British Journal of Cancer , 130, 406-416. https://doi.org/10.1038/s41416-023-02537-y
Santos, P.M., Adamik, J., Howes, T.R., Du, S., Vujanovic, L., Warren, S., et al . (2020) Impact of Checkpoint Blockade on Cancer Vaccine-Activated CD8+ T Cell Responses. Journal of Experimental Medicine , 217, e20191369. https://doi.org/10.1084/jem.20191369